SO-24 Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase 2 VELO trial
Ciardiello, D., Napolitano, S., De Falco, V., Martini, G., Martinelli, E., Della Corte, C., Esposito, L., Famiglietti, V., Di Liello, A., Avallone, A., Cardone, C., De Stefano, A., Montesarchio, V., Zampino, M., Fazio, N., Del Tufo, S., Di Maio, M., De Vita, F., Altucci, L., Marrone, F., Ciardiello, F., Troiani, T.
Published in Annals of oncology (01.06.2023)
Published in Annals of oncology (01.06.2023)
Get full text
Journal Article
Genomic profiling of non-oncogene-addicted aNSCLC using liquid biopsy. A single institution Italian experience
Di Liello, R., Viscardi, G., Sparano, F., Della Corte, C.M., Iacovino, M.L., Paragliola, F., Famiglietti, V., Di Liello, A., Ciardiello, F., Morgillo, F.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
17PGenomic profiling of non-oncogene-addicted aNSCLC using liquid biopsy. A single institution Italian experience
Di Liello, R, Viscardi, G, Sparano, F, Della Corte, C M, Iacovino, M L, Paragliola, F, Famiglietti, V, Di Liello, A, Ciardiello, F, Morgillo, F
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article
P-199 Baseline neutrophil to lymphocyte ratio predicts survival in patients with metastatic colorectal cancer treated with cetuximab plus avelumab (CAVE) as a rechallenge strategy
Ciardiello, D., Famiglietti, V., Napolitano, S., Terminiello, M., Borrelli, C., Vitiello, P., Pietrantonio, F., Avallone, A., Normanno, N., Maiello, E., Latiano, T., Cremolini, C., Santabarbara, G., Pinto, C., Santini, D., Esposito, L., Di Liello, A., Troiani, T., Ciardiello, F., Martinelli, E., Martini, G.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article